Press Release
CT Pharma Research Announces the Establishment of CT Pharma Pharmaceuticals and Biotechnology Industry and Foreign Trade Joint Stock Company
[Türkiye, March 7, 2023] - CT Pharma Research, a leading pharmaceutical research and development company, is pleased to announce the establishment of CT Pharma Pharmaceuticals and Biotechnology Industry and Foreign Trade Joint Stock Company. This new sister company will be responsible for the licensing, sales, and marketing activities of the pharmaceutical products developed by CT Pharma Research.
CT Pharma Pharmaceuticals and Biotechnology Industry and Foreign Trade Joint Stock Company was established in response to the growing demand for innovative, customized, and sustainable solutions in the healthcare sector. By leveraging our expertise in generic pharmaceuticals, we aim to provide our customers with the highest quality products and services that address their unique needs.
At CT Pharma Research, we are committed to listening to the needs of our customers and creating customized solutions that deliver the best possible outcomes. With the establishment of CT Pharma Pharmaceuticals and Biotechnology Industry and Foreign Trade Joint Stock Company, we will be better equipped to meet the demands of the healthcare sector and to provide our customers with the highest level of service.
We are excited about the opportunities that the establishment of CT Pharma Pharmaceuticals and Biotechnology Industry and Foreign Trade Joint Stock Company will bring to our organization and to our customers. We believe that this new sister company will enable us to better serve the healthcare sector and to continue to deliver innovative and sustainable solutions that make a real difference in people's lives.
For more information about CT Pharma Pharmaceuticals and Biotechnology Industry and Foreign Trade Joint Stock Company and our other sister companies, TFLL Pharma and Planto Health, please visit our website at www.ctpharma.com.tr
Contact: Şerhan Şimşek, PhD Co-Founder
Contact: Chem. Eng. Semra Aktaş Şimşek, Co-Founder
CT Pharma Research
Phone: +90 262 642 04 21
Email: info@ctpharma.com.tr
Website: www.ctpharma.com.tr
